Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

NCT02072616 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02072616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02072616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.
Lead sponsor
University Hospital, Rouen
Phase
Not applicable
Overall status
Terminated
Start date
September 16, 2014
Completion date
February 28, 2022
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ca 19.9, circulating tumor cells, circulating tumor dna (kras), pancreatic adenocarcinoma